An Ottawa company that helps law enforcement agencies, hospitals and medical laboratories track samples of blood, saliva and other bodily fluids collected from patients and crime scenes has received a cash infusion from a U.S. health-tech firm to fund its southern expansion push.
STACS DNA said Tuesday that InVita Healthcare Technologies has acquired a majority stake in the company in a deal that closed earlier this month. Further financial details of the transaction were not disclosed.
STACS president and chief operating officer Jocelyn Tremblay said the new investment will give the bootstrapped 35-person firm the financial backing it needs to scale up in the U.S. market.